Terms: = Thyroid cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824
21 results:
1. Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated thyroid cancers.
Toro-Tobon D; Morris JC; Hilger C; Peskey C; Durski JM; Ryder M
Thyroid; 2024 Jan; 34(1):70-81. PubMed ID: 37917101
[No Abstract] [Full Text] [Related]
3. Medullary carcinoma of the ampulla has distinct clinicopathologic characteristics including common association with microsatellite instability and PD-L1 expression.
Xue Y; Balci S; Pehlivanoglu B; Muraki T; Memis B; Saka B; Kim G; Bandyopadhyay S; Knight J; El-Rayes B; Kooby D; Maithel SK; Sarmiento J; Basturk O; Reid MD; Adsay V
Hum Pathol; 2023 Jan; 131():38-46. PubMed ID: 36502926
[TBL] [Abstract] [Full Text] [Related]
4. p53 Pathway Inactivation Drives smarcb1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition.
Oppel F; Shao S; Gendreizig S; Zimmerman MW; Schürmann M; Flavian VF; Goon P; Chi SN; Aster JC; Sudhoff H; Look AT
Mol Cancer Ther; 2022 Nov; 21(11):1689-1700. PubMed ID: 36099437
[TBL] [Abstract] [Full Text] [Related]
5. cancer-Predisposition Genetic Analysis in Children with Brain Tumors Treated at a Single Institution in Japan.
Fukushima H; Suzuki R; Yamaki Y; Hosaka S; Inaba M; Muroi A; Tsurubuchi T; Morii W; Noguchi E; Takada H
Oncology; 2022; 100(3):163-172. PubMed ID: 34959239
[TBL] [Abstract] [Full Text] [Related]
6. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
[TBL] [Abstract] [Full Text] [Related]
7. ini1-Deficient thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of ini1 Expression in thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract] [Full Text] [Related]
8. SMARCA4 (BRG1) and smarcb1 (ini1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma.
Gandhi JS; Alnoor F; Sadiq Q; Solares J; Gradowski JF
Pathol Res Pract; 2021 Mar; 219():153341. PubMed ID: 33581550
[TBL] [Abstract] [Full Text] [Related]
9. smarcb1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
Kezlarian BE; Lin O; Dogan S
J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
[TBL] [Abstract] [Full Text] [Related]
10. SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer.
Stachowiak M; Szymanski M; Ornoch A; Jancewicz I; Rusetska N; Chrzan A; Demkow T; Siedlecki JA; Sarnowski TJ; Sarnowska E
IUBMB Life; 2020 Jun; 72(6):1175-1188. PubMed ID: 32073734
[TBL] [Abstract] [Full Text] [Related]
11. Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodine.
Zhang X; Higuchi T; Tomonaga H; Lamid-Ochir O; Bhattarai A; Nguyen-Thu H; Taketomi-Takahashi A; Hirasawa H; Tsushima Y
Nucl Med Commun; 2020 Apr; 41(4):350-355. PubMed ID: 32032192
[TBL] [Abstract] [Full Text] [Related]
12. smarcb1 (ini1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with ini1 loss.
Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
[TBL] [Abstract] [Full Text] [Related]
13. Differences in Mutational Profile between Follicular thyroid Carcinoma and Follicular thyroid Adenoma Identified Using Next Generation Sequencing.
Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
[TBL] [Abstract] [Full Text] [Related]
14. Myoepithelioma-like tumor of the vulvar region showing infiltrative growth and harboring only a few estrogen receptor-positive cells: A case report.
Kojima Y; Tanabe M; Kato I; Motoi T; Kimura M; Sawazumi T; Tanaka R; Chiba S; Otani M; Inayama Y
Pathol Int; 2019 Mar; 69(3):172-176. PubMed ID: 30737997
[TBL] [Abstract] [Full Text] [Related]
15. INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors.
Rooper LM; Bishop JA; Westra WH
Am J Surg Pathol; 2018 May; 42(5):665-671. PubMed ID: 29438167
[TBL] [Abstract] [Full Text] [Related]
16. Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
Oishi N; Kondo T; Ebina A; Sato Y; Akaishi J; Hino R; Yamamoto N; Mochizuki K; Nakazawa T; Yokomichi H; Ito K; Ishikawa Y; Katoh R
Mod Pathol; 2017 Nov; 30(11):1527-1537. PubMed ID: 28731042
[TBL] [Abstract] [Full Text] [Related]
17. Large cell lung carcinoma with rhabdoid phenotype: Report of a rare entity presenting with chest wall involvement.
Bahadur S; Pujani M; Jetley S; Khetrapal S; Raina PK
J Cancer Res Ther; 2015; 11(3):657. PubMed ID: 26458655
[TBL] [Abstract] [Full Text] [Related]
18. cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary.
Shih J; Bashir B; Gustafson KS; Andrake M; Dunbrack RL; Goldstein LJ; Boumber Y
J Natl Compr Canc Netw; 2015 Aug; 13(8):947-52. PubMed ID: 26285240
[TBL] [Abstract] [Full Text] [Related]
19. Head and neck manifestations of 22q11.2 deletion syndromes.
Marom T; Roth Y; Goldfarb A; Cinamon U
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):381-7. PubMed ID: 21861138
[TBL] [Abstract] [Full Text] [Related]
20. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases.
Folpe AL; Lloyd RV; Bacchi CE; Rosai J
Am J Surg Pathol; 2009 Aug; 33(8):1179-86. PubMed ID: 19417583
[TBL] [Abstract] [Full Text] [Related]
[Next]
